Ty-38c

N/A

Report date: 2023/11/24 17:18:06

NME

Base Information

Drug NameTy-38c

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitors

TargetsFAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase

Therapy Area/IndicationsTuberculosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTydock Pharma Srl

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTydock Pharma Srl

Active IndicationsN/A

Inactive IndicationsTuberculosis

ATC CodeN/A